Pharming receives positive recommendation from NICE for Joenja(leniolisib) as a treatment for APDS
For media and investors only Joenja® is the first and only medicine…
Pharming Group to participate in March investor conference
Leiden, the Netherlands, February 28, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq:…
Pharming Group to participate in February investor conference
Leiden, the Netherlands, February 10, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq:…
Pharming Technologies B.V. declares unconditional and completes the recommended cash offer to the shareholders of Abliva AB (publ) and extends the acceptance period
This press release is not an offer, whether directly or indirectly, in…